HALAS GUS D 4
4 · OptimizeRx Corp · Filed Aug 18, 2023
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
HALAS GUS D
Director
Transactions
- Exercise/Conversion
Common Stock
2023-06-07+4,637→ 70,865 total - Award
Restricted Stock Units
2023-06-07+10,061→ 10,061 total→ Common Stock (10,061 underlying) - Exercise/Conversion
Restricted Stock Units
2023-06-07−4,637→ 0 total→ Common Stock (4,637 underlying)
Footnotes (4)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On June 7, 2022 the reporting person was granted 4,637 restricted stock units which vested in full on June 7, 2023.
- [F3]Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock.
- [F4]The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders.